1,000 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Bought by Measured Wealth Private Client Group LLC

Measured Wealth Private Client Group LLC acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 1,000 shares of the biotechnology company’s stock, valued at approximately $258,000.

Other large investors also recently bought and sold shares of the company. Westfield Capital Management Co. LP raised its holdings in Axon Enterprise by 184.3% during the third quarter. Westfield Capital Management Co. LP now owns 696,193 shares of the biotechnology company’s stock worth $138,535,000 after purchasing an additional 451,350 shares in the last quarter. Vaughan Nelson Investment Management L.P. raised its stake in shares of Axon Enterprise by 18.4% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 104,587 shares of the biotechnology company’s stock worth $27,019,000 after buying an additional 16,230 shares in the last quarter. BKM Wealth Management LLC purchased a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $32,000. Sumitomo Mitsui Trust Holdings Inc. grew its holdings in Axon Enterprise by 0.3% during the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 147,345 shares of the biotechnology company’s stock worth $29,320,000 after acquiring an additional 495 shares during the period. Finally, International Assets Investment Management LLC purchased a new position in Axon Enterprise in the fourth quarter worth $39,907,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the topic of a number of recent analyst reports. JMP Securities upped their price target on shares of Axon Enterprise from $320.00 to $375.00 and gave the stock a “market outperform” rating in a research note on Wednesday. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. TheStreet downgraded Axon Enterprise from a “b” rating to a “c+” rating in a research note on Tuesday, February 27th. JPMorgan Chase & Co. boosted their target price on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research report on Thursday, April 11th. Finally, Morgan Stanley raised their price target on Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a research report on Friday, April 26th. Two equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $323.09.

Get Our Latest Report on Axon Enterprise

Axon Enterprise Trading Up 0.6 %

NASDAQ:AXON traded up $1.80 on Friday, reaching $318.55. The stock had a trading volume of 279,175 shares, compared to its average volume of 468,981. The company has a market cap of $24.04 billion, a price-to-earnings ratio of 138.50 and a beta of 0.91. Axon Enterprise, Inc. has a 12-month low of $175.37 and a 12-month high of $329.87. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66. The firm’s fifty day moving average is $308.83 and its two-hundred day moving average is $265.28.

Axon Enterprise (NASDAQ:AXONGet Free Report) last announced its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.29. The firm had revenue of $432.14 million for the quarter, compared to analyst estimates of $418.97 million. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. Equities analysts expect that Axon Enterprise, Inc. will post 2.44 EPS for the current fiscal year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.